No products in the cart.
U.S. FILLED & FINISHED | ≥99% COA-VERIFIED PURITY
LC-MS VERIFIED IDENTITY | INDEPENDENTLY TESTED
KLOW-80 is a four-compound research blend combining GHK-Cu, KPV, BPC-157, and TB-500 in a single vial. This guide breaks down exactly what each component is, links to the individual research on each, and is direct about what is and is not known: these four compounds have each been studied independently, but not as this specific combination.
KLOW-80: What’s Actually In This Peptide Blend
KLOW-80 combines four individually well-studied research peptides into a single vial. Rather than treating it as one novel compound, the honest way to understand KLOW-80 is to look at what each of its four components has actually been studied for on its own.
KLOW-80 Composition
| Component | Amount | Primary research focus |
|---|---|---|
| GHK-Cu | 50 mg | Copper-peptide, skin and extracellular matrix biology |
| KPV | 10 mg | Tripeptide fragment, anti-inflammatory signaling research |
| BPC-157 | 10 mg | Gastric-derived peptide, tissue repair mechanisms |
| TB-500 | 10 mg | Thymosin beta-4 fragment, cytoskeletal and cell migration research |
Research framing: This article is intended for educational and research-context discussion only. KLOW-80 is a research blend sold for laboratory investigation only. This content does not provide medical advice, dosing guidance, or treatment recommendations of any kind.
The Four Components, Briefly
GHK-Cu
A naturally occurring copper tripeptide (glycyl-L-histidyl-L-lysine bound to copper), studied extensively for its role in collagen cross-linking and skin extracellular matrix biology.
KPV
A tripeptide (lysine-proline-valine) derived from the C-terminal sequence of alpha-MSH, studied for its ability to modulate NF-κB and MAP-kinase inflammatory signaling largely independent of classical melanocortin receptors.
BPC-157
A 15-amino-acid pentadecapeptide derived from a gastric juice protein, studied for proposed mechanisms including VEGF-driven angiogenesis and nitric oxide signaling.
TB-500
A synthetic fragment of thymosin beta-4, studied for actin-sequestering activity and its role in cell migration signaling.
Each of these four peptides has an independent research literature behind it. None of that literature examines this specific four-compound combination as a unit. A blend of well-studied components is not the same as a well-studied blend, and that distinction matters when reading about KLOW-80.
Where to Read the Actual Research
For the individual mechanism, evidence, and reference details behind each component, see our dedicated guides:
KLOW-80 vs GLOW-70
KLOW-80 and GLOW-70 share the same GHK-Cu, BPC-157, and TB-500 base. KLOW-80 adds a fourth component, KPV, at 10mg. For that comparison, see our overview of GLOW-70.
KLOW-80 – Research Grade, ≥99% (HPLC)
Badger Compounds supplies KLOW-80 as a lyophilized research blend, six-round independently tested per batch with publicly viewable COAs. For qualified laboratory research use only.
View KLOW-80Disclaimer: This article is for informational and educational purposes only. Products and compounds discussed are intended for research use only and are not for human consumption, veterinary use, clinical use, diagnostic use, food use, supplement use, pharmaceutical use, cosmetic use, or any consumer application. Statements have not been evaluated by the FDA. This content does not provide medical advice, treatment guidance, dosing information, or recommendations for personal use.
